亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation

医学 免疫学 干细胞 巨细胞病毒 造血干细胞移植 免疫 移植 造血 免疫系统 病毒学 人类免疫缺陷病毒(HIV) 内科学 病毒性疾病 疱疹病毒科 生物 遗传学
作者
Sylvia Borchers,S. Luther,Ulrich Lips,N. Hahn,Julia Kontsendorn,M. Stadler,Stefanie Buchholz,Helmut Diedrich,Matthias Eder,Ulrike Koehl,Arnold Ganser,Eva M. Weissinger
出处
期刊:Transplant Infectious Disease [Wiley]
卷期号:13 (3): 222-236 被引量:55
标识
DOI:10.1111/j.1399-3062.2011.00626.x
摘要

BACKGROUND: Reactivation of cytomegalovirus (CMV) is a major cause of morbidity after allogeneic hematopoietic stem cell transplantation (HSCT). In healthy individuals, virus-specific T cells (CMV-CTL) control the reactivation of latent CMV. The monitoring of virus-epitope-binding CD8(+) T cells using major histocompatibility complex-I-peptide complexes (tetramers) has recently been established, allowing assessment of the reconstitution of CMV-CTL post HSCT. PATIENTS AND METHODS: In order to study immune reconstitution and reactivation control through CMV-CTL, we regularly monitored all patients undergoing allogeneic HSCT in our department for 2 years, who matched at least 1 of 6 commercially available tetramers for common human leukocyte antigen (HLA) types. To verify risk factors for CMV reactivations in our cohorts, clinical characteristics of all patients transplanted within the last 10 years were included in statistical analyses determining the relative risk for single and recurrent CMV reactivations. RESULTS: As expected, CMV serostatus, HLA match, and donor source significantly influenced the risk of recurrent CMV reactivation. Applying CMV-CTL tetramer monitoring for 2 years allowed the monitoring of 114 (85%) of 134 patients, by testing a set of tetramers representing 6 epitopes from 3 different CMV proteins. The presence of CMV-CTL before day + 50 and their expansion post reactivation seem to protect against recurrent CMV reactivations. The mean number of CMV-CTL by day +100 was >5-fold higher in the recipient CMV-positive/donor-positive (R +/D +) group (91/μL) compared with the R +/ D- (13/μL) and the R -/D +(2/μL) group. Seventy-nine percent of patients from the R +/D + setting recovered >10 CMV-CTL per μL by day + 100, while almost 50% of the other groups failed to mount a CMV-specific response by that time (R +/D -: 58%; R -/D +: 43%). CONCLUSION: Tetramer monitoring can help to predict (recurrent) CMV reactivation and is a useful approach to monitor individual patients with increased risk for recurrent reactivation post HSCT; thus, it could help to identify patients in need of adoptive transfer of CMV-CTL or to optimize the use of antiviral drugs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
5秒前
我很好完成签到 ,获得积分10
8秒前
9秒前
11秒前
15秒前
现代的初之完成签到,获得积分10
18秒前
合适雨完成签到,获得积分10
25秒前
39秒前
elsa622完成签到 ,获得积分10
40秒前
端庄的如松完成签到,获得积分10
46秒前
打打的应助被科研通管家采纳,获得10
47秒前
47秒前
过时的行云完成签到,获得积分10
59秒前
1分钟前
柔弱藏花完成签到,获得积分10
1分钟前
iman完成签到,获得积分10
1分钟前
1分钟前
勤恳的从蕾完成签到,获得积分10
1分钟前
1分钟前
ccccccc完成签到,获得积分10
1分钟前
ccccccc发布了新的文献求助10
1分钟前
wakawaka完成签到 ,获得积分10
1分钟前
1分钟前
独特问梅完成签到,获得积分10
1分钟前
单薄的白翠完成签到,获得积分10
1分钟前
科研通AI6.4的应助被精明凝海采纳,获得10
2分钟前
MchemG的应助被TXZ06采纳,获得30
2分钟前
2分钟前
2分钟前
Heaven发布了新的文献求助10
2分钟前
单薄的飞风完成签到,获得积分10
2分钟前
2分钟前
null的应助被科研通管家采纳,获得20
2分钟前
2分钟前
小二郎的应助被科研通管家采纳,获得10
2分钟前
null的应助被科研通管家采纳,获得20
2分钟前
悦兮完成签到 ,获得积分10
2分钟前
失眠的热狗完成签到,获得积分10
2分钟前
zhanghao完成签到,获得积分10
3分钟前
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179896
求助须知:如何正确求助?哪些是违规求助? 9570103
关于积分的说明 21808343
捐赠科研通 7775692
什么是DOI,文献DOI怎么找? 3433193
关于科研通互助平台的介绍 2557334
邀请新用户注册赠送积分活动 2478881